With the Omicron variant of Covid-19 wreaking worldwide havoc, the demand for tests is exploding. Companies producing test kits are living through a golden age. But it is mainly Chinese companies which are scooping up the profits, with just a few French test-makers jumping on the bandwagon.
"The stock price of Orient Bio has gone crazy!" according to Chinese market analyst Finance World, commenting on the performance of Zhejiang Orient Gene Biotech, owner of Healgen Scientific, one of 56 companies that the government in Paris has allowed to sell autotests on the French market.
